STAT6 is an attractive therapeutic target for human cancers and other human diseases. Starting from a STAT6 ligand with
No takes yet. Share an insight, caveat, or question.
Kaneshige et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: